We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Lactoferrin and hematoma detoxification after intracerebral hemorrhage.
- Authors
Zhao, Xiurong; Kruzel, Marian; Aronowski, Jaroslaw
- Abstract
In this minireview we discuss the role of lactoferrin (LTF) in detoxifying hematoma after intracerebral hemorrhage (ICH). Subsequent to ICH, neutrophils enter the ICH-affected brain, where they release various granule contents, including LTF. LTF is an iron-binding glycoprotein that binds Fe3+ with high affinity. Unlike other iron-binding proteins, LTF can retain Fe3+ at the low pH associated with inflamed tissue. LTF's ability to sequester Fe3+ is of particular importance to ICH pathogenesis, because large quantities of free iron, which is pro-oxidative and pro-inflammatory, are generated in the ICH-affected brain owing to blood hemolysis. LTF delivered to ICH-affected brain, either as a therapeutic agent or through infiltrated polymorphonuclear neutrophils (cells containing high levels of LTF), could limit the pathogenesis of ICH. LTF is a protein with a high isoelectric point (8.7), a property that enables it to bind to negatively-charged apoptotic cells or proteins. Here, LTF could act as a bridging molecule that couples the apoptotic cells to LTF receptors on the cellular membranes of microglia/macrophages to facilitate the efferocytosis/erythrophagocytosis of apoptotic cells and damaged red blood cells. Thus, by virtue of sequestrating iron and facilitating efferocytosis, LTF may contribute to hematoma detoxification and hematoma/inflammation resolution after ICH.
- Subjects
LACTOFERRIN; CEREBRAL hemorrhage; ERYTHROCYTES; HEMATOMA; CELL receptors; CELL membranes
- Publication
Biochemistry & Cell Biology, 2021, Vol 99, Issue 1, p97
- ISSN
0829-8211
- Publication type
Article
- DOI
10.1139/bcb-2020-0116